MedTrace Logo

DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors

NCT06009835 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2023-08-24

No results posted yet for this study

Summary

This study is an open, single center clinical study targeting solid tumor patients who have exhausted or cannot tolerate standard treatment regimens. The main purpose of this study is to investigate the feasibility, efficacy, and safety of selecting treatment regimens based on DOTr/DOTa results for solid tumor patients who have exhausted or cannot tolerate standard treatment regimens.

Conditions

Interventions

OTHER

Recommended treatment plan

Develop a final treatment plan based on DOTr/DOTA test results, MTB consultation expert opinions, and drug accessibility

Sponsors & Collaborators

  • Tianjin Medical University Second Hospital

    lead OTHER

Principal Investigators

  • HaiTao Wang, Ph.D · Tianjin Medical University Second Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-07
Primary Completion
2024-08-07
Completion
2024-09-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06009835 on ClinicalTrials.gov